BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20181814)

  • 1. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial.
    Kempf K; Herder C; Erlund I; Kolb H; Martin S; Carstensen M; Koenig W; Sundvall J; Bidel S; Kuha S; Tuomilehto J
    Am J Clin Nutr; 2010 Apr; 91(4):950-7. PubMed ID: 20181814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coffee Consumption Increases the Antioxidant Capacity of Plasma and Has No Effect on the Lipid Profile or Vascular Function in Healthy Adults in a Randomized Controlled Trial.
    Agudelo-Ochoa GM; Pulgarín-Zapata IC; Velásquez-Rodriguez CM; Duque-Ramírez M; Naranjo-Cano M; Quintero-Ortiz MM; Lara-Guzmán OJ; Muñoz-Durango K
    J Nutr; 2016 Mar; 146(3):524-31. PubMed ID: 26843588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of coffee polyphenols and plasma biomarkers of diabetes risk in healthy Japanese women.
    Lee AH; Tan L'; Hiramatsu N; Ishisaka A; Alfonso H; Tanaka A; Uemura N; Fujiwara Y; Takechi R
    Nutr Diabetes; 2016 Jun; 6(6):e212. PubMed ID: 27270110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomic Response to Coffee Consumption.
    Kuang A; Erlund I; Herder C; Westerhuis JA; Tuomilehto J; Cornelis MC
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioappearance and pharmacokinetics of bioactives upon coffee consumption.
    Lang R; Dieminger N; Beusch A; Lee YM; Dunkel A; Suess B; Skurk T; Wahl A; Hauner H; Hofmann T
    Anal Bioanal Chem; 2013 Oct; 405(26):8487-503. PubMed ID: 23982107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3N/EPIC cohort study.
    Sartorelli DS; Fagherazzi G; Balkau B; Touillaud MS; Boutron-Ruault MC; de Lauzon-Guillain B; Clavel-Chapelon F
    Am J Clin Nutr; 2010 Apr; 91(4):1002-12. PubMed ID: 20147471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Habitual Coffee and Tea Consumption and Cardiometabolic Biomarkers in the UK Biobank: The Role of Beverage Types and Genetic Variation.
    Cornelis MC; van Dam RM
    J Nutr; 2020 Oct; 150(10):2772-2788. PubMed ID: 32805014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein partially mediates the inverse association between coffee consumption and risk of type 2 diabetes: The UK Biobank and the Rotterdam study cohorts.
    Ochoa-Rosales C; van der Schaft N; Braun KVE; Ho FK; Petermann-Rocha F; Ahmadizar F; Kavousi M; Pell JP; Ikram MA; Celis-Morales CA; Voortman T
    Clin Nutr; 2023 May; 42(5):661-669. PubMed ID: 36940600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: a survey and cross sectional study.
    Naidoo N; Chen C; Rebello SA; Speer K; Tai ES; Lee J; Buchmann S; Koelling-Speer I; van Dam RM
    Nutr J; 2011 May; 10():48. PubMed ID: 21569629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study.
    Rebello SA; Chen CH; Naidoo N; Xu W; Lee J; Chia KS; Tai ES; van Dam RM
    Nutr J; 2011 Jun; 10():61. PubMed ID: 21631956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes.
    Stutz B; Ahola AJ; Harjutsalo V; Forsblom C; Groop PH;
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):470-476. PubMed ID: 29501444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coffee consumption, obesity and type 2 diabetes: a mini-review.
    Santos RM; Lima DR
    Eur J Nutr; 2016 Jun; 55(4):1345-58. PubMed ID: 27026242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Habitual coffee intake and plasma lipid profile: Evidence from UK Biobank.
    Zhou A; Hyppönen E
    Clin Nutr; 2021 Jun; 40(6):4404-4413. PubMed ID: 33487505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin.
    Mure K; Maeda S; Mukoubayashi C; Mugitani K; Iwane M; Kinoshita F; Mohara O; Takeshita T
    Nutrition; 2013; 29(7-8):982-7. PubMed ID: 23602227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study.
    Williams CJ; Fargnoli JL; Hwang JJ; van Dam RM; Blackburn GL; Hu FB; Mantzoros CS
    Diabetes Care; 2008 Mar; 31(3):504-7. PubMed ID: 18070989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of coffee on cholesterol and apolipoproteins, corroborated by caffeine levels.
    Sedor FA; Schneider KA; Heyden S
    Am J Prev Med; 1991; 7(6):391-6. PubMed ID: 1790048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial.
    Corrêa TA; Rogero MM; Mioto BM; Tarasoutchi D; Tuda VL; César LA; Torres EA
    Nutrition; 2013; 29(7-8):977-81. PubMed ID: 23510568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roasting intensity of naturally low-caffeine Laurina coffee modulates glucose metabolism and redox balance in humans.
    Di Girolamo FG; Mazzucco S; Situlin R; Mohorko N; Jenko-Pražnikar Z; Petelin A; Tence M; Pišot R; Navarini L; Biolo G
    Nutrition; 2016 Sep; 32(9):928-36. PubMed ID: 27158053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee intake and cardiovascular disease: virtue does not take center stage.
    Montagnana M; Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2012 Mar; 38(2):164-77. PubMed ID: 22422331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons.
    Andersson U; Berger K; Högberg A; Landin-Olsson M; Holm C
    Eur J Clin Nutr; 2012 May; 66(5):585-90. PubMed ID: 22166897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.